Charles River Laboratories (United States)
Charles River Laboratories International, Inc. is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the pharmaceutical, medical device and biotechnology industries. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Charles River Laboratories (United States), United States, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
51%
Total
Publications
2.5K
Total Open
Publications
1.3K
Total
Citations
44K
Open Access
Percentage
51%
Total
Publications
2.5K
Total Open
Publications
1.3K
Total
Citations
44K
Breakdown
Publisher Open
24%
Both
18%
Other Platform Open
9%
Closed
49%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 21%
218
Hybrid 35%
355
No Guarantees 44%
449
Other Platform Open
Domain 80%
535
Institution 23%
155
Preprint 12%
80
Other Internet 8%
53
Public 7%
48
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 529 |
Europe PMC | Domain | 255 |
DOI | Other Internet | 51 |
bioRxiv | Preprint | 44 |
Semantic Scholar | Public | 39 |
University of Cambridge - Apollo | Institution | 23 |
University College London - UCL Discovery | Institution | 22 |
DANS - Data Archiving and Networked Services - NARCIS - National Academic Research and Collaborations Information System | Institution | 15 |
University of Dundee - Discovery Research Portal | Institution | 14 |
Research Square | Preprint | 13 |